Nivolumab & Ipilimumab + Zirdafulven for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Jun 2023: Trial started, NCT05933265
  2. 6 Jul 2023: Trial registered, NCT05933265

The trials

NCT05933265: Study of LP-184 in Patients With Advanced Solid Tumors

State
Under way
Phase
Phase 1 and Phase 2
People
64 taking part
Started
9 Jun 2023
Primary completion
28 Jul 2026
Arms
Supplement D
Results
None posted
  1. 9 Jun 2023: Trial started
  2. 6 Jul 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.